Adagio Medical Announces Completion of Enrollment in Cryocure-VT Trial, Maps the Pathway to CE-Mark of vCLAS™ VT Ablation Catheter ...Middle East

LAGUNA HILLS, Calif., May 3, 2023 /PRNewswire/ -- Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), announced the completion of enrollment in its Cryocure-VT trial (NCT # 04893317) of ultra-low...

Read More Details
Finally We wish PressBee provided you with enough information of ( Adagio Medical Announces Completion of Enrollment in Cryocure-VT Trial, Maps the Pathway to CE-Mark of vCLAS™ VT Ablation Catheter )

Also on site :

• Popular Chocolate Brand Recalled Nationwide
• Surging travel in Europe spikes concerns over tourism's drawbacks
• Bianca Censori Goes Braless in Tight Sheer Top, Micro Shorts in New Photos